Steven G. Reed, PhD

Head of Research and Development, IDRI Founder

Steve Reed is the founder and Head of Research and Development of the Infectious Disease Research Institute. Dr. Reed also co-founded Corixa Corporation in 1994, where he served as Chief Scientific Officer until leaving in 2004. His academic appointments include Professor of Medicine at Cornell University Medical College in New York and Research Professor of Pathobiology at the University of Washington. He serves on several editorial review committees, has served as a member of the Tropical Medicine Review Board of the National Institutes of Health, and is a member of the Vaccine Development Steering Committee of the World Health Organization.

Dr. Reed was born in rural eastern Washington, graduated from Whitman College in 1973, and received a PhD in Microbiology and Immunology from the University of Montana in 1979. That year he was appointed as Scientist of the National Institute of Amazon Research in Manaus, Brazil, where he directed research on tropical diseases. Dr. Reed joined Cornell University Medical College in 1980 as Assistant Professor of Medicine, continuing to work in Brazil as manager of the Cornell-Bahia program in International Medicine. He joined the Seattle Biomedical Research Institute in 1984 where he worked until founding IDRI in 1993. Dr. Reed’s research interests have focused on the immunology of intracellular infections, and on the development of vaccines and diagnostics for both cancer and infectious diseases. He has more than 170 original articles, several book chapters, and holds 59 issued patents for diagnostics, vaccines, and therapeutics of infectious diseases and cancer.

Recent Publications

  1. Fox CB, Anderson RC, Dutill TS, Goto Y, Reed SG, Vedvick TS. “Monitoring the Effects of Component Structure and Source on Formulation Stability and Adjuvant Activity of Oil-in-Water Emulsions.” 2008 Colloids surface B Biointerfaces. 65, 98-105.
  2. Coler, R.N., Y. Goto, L. Bogatzki, V. Raman, and S.G. Reed. Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cells. 2007 Infect. Immun. 75:4648-4654.
  3. Goto, Y., L.Y. Bogatzki, S. Bertholet, R.N. Coler, and S.G. Reed. Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant. 2007 Vaccine. 25:7450-7458.
  4. Duthie, M.S., S.T. Reece, R. Lahiri, W. Goto, V.S. Raman, J. Kaplan, G.I. Ireton, S. Bertholet, T.P. Gillis, J.L. Krahenbuhl, and S.G. Reed. Antigen-specific cellular and humoral responses are induced by intradermal m. leprae infection of the mouse ear. 2007 Infect Immun. 75:5290-5297.
  5. Goto, Y., R.N. Coler and S.G. Reed. Bioinformatic identification of tandem repeat antigens of Leishmania donovani complex. 2007 Infect. Immun. 75:846-851.
  6. Duthie, M.S., W. Goto, G.C. Ireton, S.T. Reece, L.P. Cardoso, C.M. Martelli, M.M. Stefani, M. Nakatani, R.C. de Jesus, E.M. Netto, M.V. Balagon, E. Tan, R.H. Gelber, Y. Maeda, M. Makino, D. Hoft, and S.G. Reed. Use of protein antigens for early serological diagnosis of leprosy. 2007 Clin Vaccine Immunol. 14:1400-1408.